- Home
- HITI vs GOSS Comparison
HITI vs GOSS Comparison
Compare HITI & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HITI
- GOSS
- Stock Information
- Founded
- HITI 2009
- GOSS 2015
- Country
- HITI Canada
- GOSS United States
- Employees
- HITI N/A
- GOSS N/A
- Industry
- HITI
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- HITI
- GOSS Health Care
- Exchange
- HITI Nasdaq
- GOSS Nasdaq
- Market Cap
- HITI 249.3M
- GOSS 237.9M
- IPO Year
- HITI N/A
- GOSS 2019
- Fundamental
- Price
- HITI $3.09
- GOSS $0.96
- Analyst Decision
- HITI Strong Buy
- GOSS Strong Buy
- Analyst Count
- HITI 1
- GOSS 5
- Target Price
- HITI $4.50
- GOSS $9.20
- AVG Volume (30 Days)
- HITI 641.5K
- GOSS 1.0M
- Earning Date
- HITI 03-14-2025
- GOSS 03-04-2025
- Dividend Yield
- HITI N/A
- GOSS N/A
- EPS Growth
- HITI N/A
- GOSS N/A
- EPS
- HITI N/A
- GOSS N/A
- Revenue
- HITI $370,017,302.00
- GOSS $105,322,000.00
- Revenue This Year
- HITI $7.52
- GOSS N/A
- Revenue Next Year
- HITI $14.03
- GOSS N/A
- P/E Ratio
- HITI N/A
- GOSS N/A
- Revenue Growth
- HITI 9.02
- GOSS N/A
- 52 Week Low
- HITI $1.57
- GOSS $0.50
- 52 Week High
- HITI $3.62
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- HITI 48.76
- GOSS 54.23
- Support Level
- HITI $3.01
- GOSS $0.83
- Resistance Level
- HITI $3.23
- GOSS $1.18
- Average True Range (ATR)
- HITI 0.15
- GOSS 0.10
- MACD
- HITI -0.02
- GOSS -0.01
- Stochastic Oscillator
- HITI 32.14
- GOSS 41.37
About HITI High Tide Inc.
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically-integrated company in the Canadian cannabis market with portfolio subsidiaries including RGR Canada Inc., Famous Brandz Inc., Kush West Distribution Inc., Smoker's Corner Ltd., Grasscity.com, Canna Cabana Inc., and KushBar Inc. The firm has established two main segments, retail and wholesale. It generates substantial revenue from retail stores' e-commerce platforms. Geographically it serves Canada, the USA, and other international markets and earns key revenue from domestic sales.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.